Integrating the roles of long and small non-coding RNA in brain function and disease

Molecular Psychiatry

Volumn 19, Issue 4, 2014, Pages 410-416

  Barry, G ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Brain development; Long non coding RNA; Neurodegeneration; Psychiatric disease; RNA targeted therapeutics; Small non coding RNA

Indexed keywords

LONG UNTRANSLATED RNA; SMALL UNTRANSLATED RNA;

AUTISM; BINDING SITE; BRAIN DEVELOPMENT; BRAIN FUNCTION; COGNITION; GENE CONTROL; GENETIC MANIPULATION; GENOME; HUMAN; MAMMAL; MENTAL DISEASE; NERVE DEGENERATION; NERVE FUNCTION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; TRANSCRIPTION REGULATION;

BRAIN; BRAIN DISEASES; HUMANS; RNA, LONG NONCODING; RNA, SMALL UNTRANSLATED;

EID: 84897113426     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.196     Document Type: Review

References (119)

1. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74
2. Liu G, Mattick JS, Taft RJ. A meta-analysis of the genomic and transcriptomic composition of complex life. Cell Cycle 2013; 12: 2061-2072
3. Barry G, Mattick JS. The role of regulatory RNA in cognitive evolution. Trends Cogn Sci 2012; 16: 497-503
4. Matera AG, Terns RM, Terns MP. Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol 2007; 8: 209-220
5. Parent JS, Martinez de Alba AE, Vaucheret H. The origin and effect of small RNA signaling in plants. Front Plant Sci 2012; 3: 179
6. Shabalina SA, Koonin EV. Origins and evolution of eukaryotic RNA interference. Trends Ecol Evol 2008; 23: 578-587
7. Grimson A, Srivastava M, Fahey B, Woodcroft BJ, Chiang HR, King N et al. Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals. Nature 2008; 455: 1193-1197
8. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233
9. Meunier J, Lemoine F, Soumillon M, Liechti A, Weier M, Guschanski K et al. Birth and expression evolution of mammalian microRNA genes. Genome Res 2013; 23: 34-45
10. Houwing S, Kamminga LM, Berezikov E, Cronembold D, Girard A, van den Elst H et al. A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in Zebrafish. Cell 2007; 129: 69-82
11. Brennecke J, Aravin AA, Stark A, Dus M, Kellis M, Sachidanandam R et al. Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell 2007; 128: 1089-1103
12. Landry CD, Kandel ER, Rajasethupathy P. New mechanisms in memory storage: piRNAs and epigenetics. Trends Neurosci 2013; 36: 535-542
13. Lee EJ, Banerjee S, Zhou H, Jammalamadaka A, Arcila M, Manjunath BS et al. Identification of piRNAs in the central nervous system. RNA 2011; 17: 1090-1099
14. Rajasethupathy P, Antonov I, Sheridan R, Frey S, Sander C, Tuschl T et al. A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity. Cell 2012; 149: 693-707
15. Skreka K, Schafferer S, Nat IR, Zywicki M, Salti A, Apostolova G et al. Identification of differentially expressed non-coding RNAs in embryonic stem cell neural differentiation. Nucleic Acids Res 2012; 40: 6001-6015
16. Kapsimali M, Kloosterman WP, de Bruijn E, Rosa F, Plasterk RH, Wilson SW. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol 2007; 8: R173
17. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005; 308: 833-838
18. De Pietri Tonelli D, Pulvers JN, Haffner C, Murchison EP, Hannon GJ, Huttner WB. miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development 2008; 135: 3911-3921
19. Cuellar TL, Davis TH, Nelson PT, Loeb GB, Harfe BD, Ullian E et al. Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration. Proc Natl Acad Sci USA 2008; 105: 5614-5619
20. Schaefer A, O'Carroll D, Tan CL, Hillman D, Sugimori M, Llinas R et al. Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 2007; 204: 1553-1558
21. Davis TH, Cuellar TL, Koch SM, Barker AJ, Harfe BD, McManus MT et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J Neurosci 2008; 28: 4322-4330
22. Kawase-Koga Y, Low R, Otaegi G, Pollock A, Deng H, Eisenhaber F et al. RNAase-III enzyme Dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci 2010; 123: 586-594
23. Nowak JS, Michlewski G. miRNAs in development and pathogenesis of the nervous system. Biochem Soc Trans 2013; 41: 815-820
24. Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, Li Y et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011; 476: 228-231
25. Sun AX, Crabtree GR, Yoo AS. MicroRNAs: regulators of neuronal fate. Curr Opin Cell Biol 2013; 25: 215-221
26. Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS et al. Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis 2010; 39: 169-180
27. Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 2006; 311: 230-232
28. Duker AL, Ballif BC, Bawle EV, Person RE, Mahadevan S, Alliman S et al. Paternally inherited microdeletion at 15q11. 2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader-Willi syndrome. Eur J Hum Genet 2010; 18: 1196-1201
29. Eacker SM, Dawson TM, Dawson VL. The interplay of microRNA and neuronal activity in health and disease. Front Cell Neurosci 2013; 7: 136
30. Krol J, Busskamp V, Markiewicz I, Stadler MB, Ribi S, Richter J et al. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 2010; 141: 618-631
31. Konopka W, Kiryk A, Novak M, Herwerth M, Parkitna JR, Wawrzyniak M et al. MicroRNA loss enhances learning and memory in mice. J Neurosci 2010; 30: 14835-14842
32. Ashraf SI, McLoon AL, Sclarsic SM, Kunes S. Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila. Cell 2006; 124: 191-205
33. Banerjee S, Neveu P, Kosik KS. A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation. Neuron 2009; 64: 871-884
34. Im HI, Kenny PJ. MicroRNAs in neuronal function and dysfunction. Trends Neurosci 2012; 35: 325-334
35. Dharap A, Nakka VP, Vemuganti R. Altered expression of PIWI RNA in the rat brain after transient focal ischemia. Stroke 2011; 42: 1105-1109
36. Rogelj B, Hartmann CE, Yeo CH, Hunt SP, Giese KP. Contextual fear conditioning regulates the expression of brain-specific small nucleolar RNAs in hippocampus. Eur J Neurosci 2003; 18: 3089-3096
37. Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, Inoue K et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 2009; 137: 1235-1246
38. Sellier C, Freyermuth F, Tabet R, Tran T, He F, Ruffenach F et al. Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep 2013; 3: 869-880
39. Wu H, Tao J, Chen PJ, Shahab A, Ge W, Hart RP et al. Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 2010; 107: 18161-18166
40. Urdinguio RG, Fernandez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M et al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010; 5: 656-663
41. Tan L, Yu JT, Hu N, Tan L. Non-coding RNAs in Alzheimer's disease. Mol Neurobiol 2013; 47: 382-393
42. Abe M, Bonini NM. MicroRNAs and neurodegeneration: role and impact. Trends Cell Biol 2013; 23: 30-36
43. Salta E, De Strooper B. Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol 2012; 11: 189-200
44. Beveridge NJ, Cairns MJ. MicroRNA dysregulation in schizophrenia. Neurobiol Dis 2012; 46: 263-271
45. Mellios N, Sur M. The emerging role of microRNAs in schizophrenia and autism secptrum disorders. Front Psychiatry 2012; 3: 39
46. Zhang Y, Dutta A, Abounader R. The role of microRNAs in glioma initiation and progression. Front Biosci (Landmark Ed) 2012; 17: 700-712
47. Zhi F, Wang S, Wang R, Xia X, Yang Y. From small to big: microRNAs as new players in medulloblastomas. Tumour Biol 2013; 34: 9-15
48. Dykens EM, Lee E, Roof E. Prader-Willi syndrome and autism spectrum disorders: an evolving story. J Neurodev Disord 2011; 3: 225-237
49. Williams GT, Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer? Nat Rev Cancer 2012; 12: 84-88
50. van Zon A, Mossink MH, Scheper RJ, Sonneveld P, Wiemer EA. The vault complex. Cell Mol Life Sci 2003; 60: 1828-1837
51. Li CC, Eaton SA, Young PE, Lee M, Shuttleworth R, Humphreys DT et al. Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol 2013; 10: 1333-1344
52. Hussain S, Sajini AA, Blanco S, Dietmann S, Lombard P, Sugimoto Y et al. NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs. Cell Rep 2013; 4: 255-261
53. Minones-Moyano E, Friedlander MR, Pallares J, Kagerbauer B, Porta S, Escaramis G et al. Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction. RNA Biol 2013; 10: 1093-1106
54. Young RS, Marques AC, Tibbit C, Haerty W, Bassett AR, Liu JL et al. Identification and properties of 1,119 candidate lincRNA loci in the Drosophila melanogaster genome. Genome Biol Evol 2012; 4: 427-442
55. Pauli A, Valen E, Lin MF, Garber M, Vastenhouw NL, Levin JZ et al. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res 2012; 22: 577-591
56. Zhang YC, Chen YQ. Long noncoding RNAs: new regulators in plant development. Biochem Biophys Res Commun 2013; 436: 111-114
57. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012; 22: 1775-1789
58. Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011; 477: 295-300
59. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A 2008; 105: 716-721
60. Li L, Liu B, Wapinski OL, Tsai MC, Qu K, Zhang J et al. Targeted disruption of Hotair leads to homeotic transformation and gene derepression. Cell Rep 2013; 5: 3-12
61. Marahrens Y, Panning B, Dausman J, Strauss W, Jaenisch R. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes Dev 1997; 11: 156-166
62. Eissmann M, Gutschner T, Hammerle M, Gunther S, Caudron-Herger M, Gross M et al. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol 2012; 9: 1076-1087
63. Nakagawa S, Ip JY, Shioi G, Tripathi V, Zong X, Hirose T et al. Malat1 is not an essential component of nuclear speckles in mice. RNA 2012; 18: 1487-1499
64. Bernard D, Prasanth KV, Tripathi V, Colasse S, Nakamura T, Xuan Z et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J 2010; 29: 3082-3093
65. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 2010; 39: 925-938
66. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 2013; 9: e1003368
67. Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013; 73: 1180-1189
68. Lv J, Cui W, Liu H, He H, Xiu Y, Guo J et al. Identification and characterization of long non-coding RNAs related to mouse embryonic brain development from available transcriptomic data. PLoS ONE 2013; 8: e71152
69. Ng SY, Johnson R, Stanton LW. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J 2012; 31: 522-533
70. Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci 2012; 13: 528-541
71. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 2012; 482: 339-346
72. Mercer TR, Mattick JS. . Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol 2013; 20: 300-307
73. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329: 689-693
74. Barry G, Briggs JA, Vanichkina DP, Poth EM, Beveridge NJ, Ratnu VS et al. The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol Psychiatry advance online publication, 30 April 2013; doi:10. 1038/mp. 2013. 45 (e-pub ahead of print)
75. Anko ML, Neugebauer KM. Long noncoding RNAs add another layer to premRNA splicing regulation. Mol Cell 2010; 39: 833-834
76. Sone M, Hayashi T, Tarui H, Agata K, Takeichi M, Nakagawa S. The mRNA-like noncoding RNA Gomafu constitutes a novel nuclear domain in a subset of neurons. J Cell Sci 2007; 120: 2498-2506
77. Gong C, Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature 2011; 470: 284-288
78. Johnson R. Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiol Dis 2012; 46: 245-254
79. Lin M, Pedrosa E, Shah A, Hrabovsky A, Maqbool S, Zheng D et al. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS ONE 2011; 6: e23356
80. Nishimoto Y, Nakagawa S, Hirose T, Okano HJ, Takao M, Shibata S et al. The long non-coding RNA nuclear-enriched abundant transcript 1-2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol Brain 2013; 6: 31
81. Petazzi P, Sandoval J, Szczesna K, Jorge OC, Roa L, Sayols S et al. Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model. RNA Biol 2013; 10: 1197-1203
82. Talkowski ME, Maussion G, Crapper L, Rosenfeld JA, Blumenthal I, Hanscom C et al. Disruption of a large intergenic noncoding RNA in subjects with neurodevelopmental disabilities. Am J Hum Genet 2012; 91: 1128-1134
83. Ziats MN, Rennert OM. Aberrant expression of long noncoding RNAs in autistic brain. J Mol Neurosci 2013; 49: 589-593
84. Lipovich L, Dachet F, Cai J, Bagla S, Balan K, Jia H et al. Activity-dependent human brain coding/noncoding gene regulatory networks. Genetics 2012; 192: 1133-1148
85. Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S et al. LncRNA pro fi le of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol 2012; 40: 2004-2012
86. Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis 2012; 48: 1-8
87. Bellin M, Marchetto MC, Gage FH, Mummery CL. Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 2012; 13: 713-726
88. Juan L, Wang G, Radovich M, Schneider BP, Clare SE, Wang Y et al. Potential roles of microRNAs in regulating long intergenic noncoding RNAs. BMC Med Genomics 2013; 6(Suppl 1): S7
89. Leucci E, Patella F, Waage J, Holmstrom K, Lindow M, Porse B et al. MicroRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep 2013; 3: 2535
90. He S, Su H, Liu C, Skogerbo G, He H, He D et al. MicroRNA-encoding long noncoding RNAs. BMC Genomics 2008; 9: 236
91. Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 2007; 13: 313-316
92. Keniry A, Oxley D, Monnier P, Kyba M, Dandolo L, Smits G et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 2012; 14: 659-665
93. Yin QF, Yang L, Zhang Y, Xiang JF, Wu YW, Carmichael GG et al. Long noncoding RNAs with snoRNA ends. Mol Cell 2012; 48: 219-230
94. Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS ONE 2013; 8: e53823
95. Paraskevopoulou MD, Georgakilas G, Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM et al. DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res 2013; 41: D239-D245
96. Faghihi MA, Zhang M, Huang J, Modarresi F, Van der Brug MP, Nalls MA et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 2010; 11: R56
97. Johnsson P, Ackley A, Vidarsdottir L, Lui WO, Corcoran M, Grander D et al. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 2013; 20: 440-446
98. Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 2013; 25: 69-80
99. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009; 106: 9362-9367
100. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010; 363: 166-176
101. Pasmant E, Sabbagh A, Vidaud M, Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011; 25: 444-448
102. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet 2009; 5: e1000459
103. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol 2010; 220: 126-139
104. Qureshi IA, Mehler MF. Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics 2013; 10: 632-646
105. Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res 2010; 1338: 20-35
106. Wang W, Kwon EJ, Tsai LH. MicroRNAs in learning, memory, and neurological diseases. Learn Mem 2012; 19: 359-368
107. Miller BH, Zeier Z, Xi L, Lanz TA, Deng S, Strathmann J et al. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A 2012; 109: 3125-3130
108. Wright C, Turner JA, Calhoun VD, Perrone-Bizzozero N. Potential Impact of miR-137 and Its Targets in Schizophrenia. Front Genet 2013; 4: 58
109. Lau P, Bossers K, Janky R, Salta E, Frigerio CS, Barbash S et al. Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med 2013; 5: 1613-1634
110. Wahlestedt C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov 2013; 12: 433-446
111. Ruberti F, Barbato C, Cogoni C. Targeting microRNAs in neurons: tools and perspectives. Exp Neurol 2012; 235: 419-426
112. Martinez T, Wright N, Lopez-Fraga M, Jimenez AI, Paneda C. Silencing human genetic diseases with oligonucleotide-based therapies. Hum Genet 2013; 132: 481-493
113. Kole R, Krainer AR, Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 2012; 11: 125-140
114. Marcus ME, Leonard JN. FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver. Pharmaceuticals (Basel) 2013; 6: 659-680
115. El Andaloussi S, Lakhal S, Mager I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev 2013; 65: 391-397
116. Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 2012; 21: R125-R134
117. Zhou J, Shum KT, Burnett JC, Rossi JJ. Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges. Pharmaceuticals (Basel) 2013; 6: 85-107
118. Muthiah M, Park IK, Cho CS. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics. Expert Opin Drug Deliv 2013; 10: 1259-1273
119. O'Mahony AM, Godinho BM, Cryan JF, O'Driscoll CM. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution. J Pharm Sci 2013; 102: 3469-3484.